{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:13:16Z","timestamp":1759342396465,"version":"build-2065373602"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.7759\/cureus.93665","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:46:51Z","timestamp":1759340811000},"source":"Crossref","is-referenced-by-count":0,"title":["A Prospective Assessment of Helicobacter pylori Eradication Regimens in Treatment-Na\u00efve Patients With Peptic Ulcer Disease"],"prefix":"10.7759","author":[{"given":"Zahra","family":"Nawaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Atta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samreen","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoukat","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazba","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiza Ali","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda Wajiha","family":"Batool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Elrefae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hifza","family":"Ishtiaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Iftikhar","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahir Iqbal","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.9734\/JAMPS\/2023\/v25i11651","article-title":"Peptic ulcer disease (PUD), diagnosis, and current medication-based management options: Schematic overview","volume":"2","author":"Srivastav Y","year":"2023","unstructured":"Srivastav Y, Kumar V, Srivastava Y, Kumar M. Peptic ulcer disease (PUD), diagnosis, and current medication-based management options: Schematic overview. J Adv Med Pharm Sci. 2023, 2:14-27. 10.9734\/JAMPS\/2023\/v25i11651","journal-title":"J Adv Med Pharm Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271284","article-title":"Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990-2019","volume":"17","author":"Abbasi-Kangevari M","year":"2022","unstructured":"Abbasi-Kangevari M, Ahmadi N, Fattahi N, et al.. Quality of care of peptic ulcer disease worldwide: A systematic analysis for the global burden of disease study 1990-2019. PLoS One. 2022, 17:e0271284. 10.1371\/journal.pone.0271284","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/9781119600206.ch49","article-title":"Peptic ulcer disease","volume":"15","author":"Yaghoobi M","year":"2022","unstructured":"Yaghoobi M, Armstrong D. Peptic ulcer disease. Yamada's Textbook of Gastroenterology. 2022, 15:924-76. 10.1002\/9781119600206.ch49","journal-title":"Yamada's Textbook of Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i3.684","article-title":"Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas","volume":"20","author":"Pereira MI","year":"2014","unstructured":"Pereira MI, Medeiros JA. Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas. World J Gastroenterol. 2014, 20:684-98. 10.3748\/wjg.v20.i3.684","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00449-x","article-title":"Helicobacter pylori infection and antibiotic resistance \u2014 from biology to clinical implications","volume":"18","author":"Tshibangu-Kabamba E","year":"2021","unstructured":"Tshibangu-Kabamba E, Yamaoka Y. Helicobacter pylori infection and antibiotic resistance \u2014 from biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2021, 18:613-29. 10.1038\/s41575-021-00449-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00008","article-title":"Meta-analysis: Duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication","volume":"147","author":"Fuccio L","year":"2007","unstructured":"Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: Duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med. 2007, 147:553-62. 10.7326\/0003-4819-147-8-200710160-00008","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw220","article-title":"Systematic review and meta-analysis: Triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment","volume":"71","author":"Puig I","year":"2016","unstructured":"Puig I, Baylina M, S\u00e1nchez-Delgado J, et al.. Systematic review and meta-analysis: Triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment. J Antimicrob Chemother. 2016, 71:2740-53. 10.1093\/jac\/dkw220","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36041","article-title":"From antibiotic resistance to antibiotic renaissance: A new era in helicobacter pylori treatment","volume":"15","author":"Godavarthy PK","year":"2023","unstructured":"Godavarthy PK, Puli C. From antibiotic resistance to antibiotic renaissance: A new era in helicobacter pylori treatment. Cureus. 2023, 15:e36041. 10.7759\/cureus.36041","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/tp-24-207","article-title":"Long-term changes in the gut microbiota before and after bismuth quadruple therapy or concomitant therapy in children with peptic ulcers receiving Helicobacter pylori eradication","volume":"13","author":"He C","year":"2024","unstructured":"He C, Wang Y, Tang Z, Lu J, Zhou Y, Huang Y. Long-term changes in the gut microbiota before and after bismuth quadruple therapy or concomitant therapy in children with peptic ulcers receiving Helicobacter pylori eradication. Transl Pediatr. 2024, 13:1947-58. 10.21037\/tp-24-207","journal-title":"Transl Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1756284820968736","article-title":"Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review","volume":"13","author":"Gisbert JP","year":"2020","unstructured":"Gisbert JP. Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review. Therap Adv Gastroenterol. 2020, 13:10.1177\/1756284820968736","journal-title":"Therap Adv Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11112658","article-title":"Identification, genome sequencing, and characterizations of Helicobacter pylori sourced from Pakistan","volume":"11","author":"Fatima A","year":"2023","unstructured":"Fatima A, Ibrahim M, Naseer A, et al.. Identification, genome sequencing, and characterizations of Helicobacter pylori sourced from Pakistan. Microorganisms. 2023, 11:2658. 10.3390\/microorganisms11112658","journal-title":"Microorganisms"},{"key":"ref12","article-title":"AGA clinical practice update on the management of refractory Helicobacter pylori infection: Expert review","volume":"160","author":"Shah SC","year":"2021","unstructured":"Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory Helicobacter pylori infection: Expert review. Gastroenterology. 2021, 160:1831-41.","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.55519\/JAMC-03-11648%20","article-title":"Primary antibiotic resistance and effectiveness of clarithromycin vs metronidazole based therapy for Helicobacter pylori infection in children","volume":"35","author":"Salman N","year":"2023","unstructured":"Salman N, Haider N, Shah M, Waris R, Naseer M, Razzaq A, Krishin J. Primary antibiotic resistance and effectiveness of clarithromycin vs metronidazole based therapy for Helicobacter pylori infection in children. J Ayub Med Coll Abbottabad. 2023, 35:390-3. 10.55519\/JAMC-03-11648%20","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12142","article-title":"Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance","volume":"19","author":"Rasheed F","year":"2014","unstructured":"Rasheed F, Campbell BJ, Alfizah H, Varro A, Zahra R, Yamaoka Y, Pritchard DM. Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance. Helicobacter. 2014, 19:387-99. 10.1111\/hel.12142","journal-title":"Helicobacter"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(01)80044-X","article-title":"Two new treatment regimens for Helicobacter pylori eradication: A randomised study","volume":"33","author":"De Francesco V","year":"2001","unstructured":"De Francesco V, Zullo A, Hassan C, Faleo D, Ierardi EN, Panella C, Morini S. Two new treatment regimens for Helicobacter pylori eradication: A randomised study. Digestive and Liver Disease. 2001, 33:676-9. 10.1016\/S1590-8658(01)80044-X","journal-title":"Digestive and Liver Disease"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.21608\/aeji.2021.92874.1173","article-title":"A New Sequential Regimen for Treatment of H. Pylori in Na\u00efve and Previously Treated Patients with\u200e Traditional Triple Therapy\u200e","volume":"1","author":"Teima AA","year":"2021","unstructured":"Teima AA, Kasemy ZA, Mehesin SA, Abo-elkheir NT, Abdel-Samiee M, Amer AA. A New Sequential Regimen for Treatment of H. Pylori in Na\u00efve and Previously Treated Patients with\u200e Traditional Triple Therapy\u200e. Afro-Egyptian J Infect End Dis. 2021, 1:404-11. 10.21608\/aeji.2021.92874.1173","journal-title":"Afro-Egyptian J Infect End Dis"},{"key":"ref17","article-title":"Addition of bismuth to standard triple therapy for Helicobacter pylori eradication: A randomised controlled trial","volume":"70","author":"Asim M","year":"2020","unstructured":"Asim M, Baqai K, Abbas Z, Laique N, Samejo SA. Addition of bismuth to standard triple therapy for Helicobacter pylori eradication: A randomised controlled trial. J Pak Med Assoc. 2020, 70:1334-9.","journal-title":"J Pak Med Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.rgmxen.2014.05.001","article-title":"Ideal treatment for Helicobacter pylori: A systematic review. (Article in Spanish)","volume":"79","author":"Sierra F","year":"2014","unstructured":"Sierra F, Forero JD, Rey M. Ideal treatment for Helicobacter pylori: A systematic review. (Article in Spanish). Rev Gastroenterol M\u00e9xico. 2014, 79:28-49. 10.1016\/j.rgmxen.2014.05.001","journal-title":"Rev Gastroenterol M\u00e9xico"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.37185\/LnS.1.1.341","article-title":"Comparative effectiveness of levofloxacin-based triple regimen and standard clarithromycin-based triple regimen in eradication of Helicobacter pylori-Insights from a peripheral hospital-based study","volume":"6","author":"Ahmed I","year":"2025","unstructured":"Ahmed I, Bano K, Shabbir K, Razzaq K, Khan RS, Iqbal Q. Comparative effectiveness of levofloxacin-based triple regimen and standard clarithromycin-based triple regimen in eradication of Helicobacter pylori-Insights from a peripheral hospital-based study. Life Sci. 2025, 6:06.","journal-title":"Life Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4091-8","article-title":"Helicobacter pylori clarithromycin resistance and treatment failure are common in the USA","volume":"61","author":"Park JY","year":"2016","unstructured":"Park JY, Dunbar KB, Mitui M, et al.. Helicobacter pylori clarithromycin resistance and treatment failure are common in the USA. Dig Dis Sci. 2016, 61:2373-80. 10.1007\/s10620-016-4091-8","journal-title":"Dig Dis Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-022-02613-y","article-title":": Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China","author":"Tang","unstructured":"Tang, X., Wang, Z., Shen, Y. : Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China. BMC Microbiol 22. 196, 1-8. 10.1186\/s12866-022-02613-y","journal-title":"BMC Microbiol 22"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S25419","article-title":"Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori","volume":"5","author":"Gisbert JP","year":"2012","unstructured":"Gisbert JP, Calvet X. Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. Clin Exp Gastroenterol. 2012, 5:23-34. 10.2147\/CEG.S25419","journal-title":"Clin Exp Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i3.347","article-title":"Epidemiology of perforated peptic ulcer: Age- and gender-adjusted analysis of incidence and mortality","volume":"19","author":"Thorsen K","year":"2013","unstructured":"Thorsen K, S\u00f8reide JA, Kval\u00f8y JT, Glomsaker T, S\u00f8reide K. Epidemiology of perforated peptic ulcer: Age- and gender-adjusted analysis of incidence and mortality. World J Gastroenterol. 2013, 19:347-54. 10.3748\/wjg.v19.i3.347","journal-title":"World J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/399049-a-prospective-assessment-of-helicobacter-pylori-eradication-regimens-in-treatment-nave-patients-with-peptic-ulcer-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:46:52Z","timestamp":1759340812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/399049-a-prospective-assessment-of-helicobacter-pylori-eradication-regimens-in-treatment-nave-patients-with-peptic-ulcer-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.93665","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}